Market Overview

UPDATE: Covidien Raises FY13 Sales-Growth Forecast

Related COV
Covidien Conference Call Highlights
US Stock Futures Surge Ahead Of Earnings, ADP Data
IRS, Eh? Tim Hortons Deal Could Lower Burger King's Tax Bill (Fox Business)

Covidien PLC (NYSE: COV) reported a 0.2% drop in its fiscal first-quarter profit and lifted raised its FY13 sales forecast.

Covidien now expects a 5% to 8% rise in its FY13 sales, versus its September view of 3% to 6% sales growth.

Covidien's quarterly profit fell to $493 million, or $1.03 per share, versus $494 million, or $1.02 per share, in the year-ago period. Excluding one-time items, its adjusted earnings declined to $1.10 per share, versus $1.13 per share.

Its sales gained 5.5% to $3.06 billion. However, analysts were expecting earnings of $1.06 per share on revenue of $3 billion.

Its gross margin declined to 57.5% from 58.7%

Covidien shares closed at $61.67 yesterday.

Posted-In: profitEarnings News Guidance


Related Articles (COV)

Around the Web, We're Loving...

Get Benzinga's Newsletters